Nanoparticles of cerium and amino acids
View Patent ↗A process for making nanoparticles of biocompatible materials is described, wherein an aqueous reaction mixture comprising cerous ion, an α-amino acid, an oxidant and water is provided along with temperature conditions to effectively form nanoparticles. These biocompatible nanoparticles may be further conjugated to biologically active agents, such as plasmid DNA, siRNA or proteins, such that a cell transfection agent is formed.
1. A process of making nanoparticles, comprising:
forming a reaction mixture comprising a solution of cerous ion, an α-amino acid, an oxidant, and water, wherein the α-amino acid is a compound of formula H 2 NCHRCOOH, wherein R is a side chain;
adjusting said reaction mixture to a pH less than about 3; and
heating or cooling said reaction mixture to a temperature in the range of about 0° C. to about 100° C. to form the nanoparticles and to directly form a dispersion of nanoparticles from the reaction mixture,
wherein said nanoparticles have a hydrodynamic diameter of less than 100 nm.
2. The process according to claim 1 , wherein said nanoparticles comprise crystalline or semi-crystalline material.
3. The process according to claim 1 , wherein said oxidant is hydrogen peroxide.
4. A process of making a conjugate, comprising:
contacting a nanoparticle formed according to the process of claim 1 , with a biologically active agent.
5. The process of claim 4 , wherein said nanoparticle comprises cerium oxide.
6. The process of claim 4 , wherein said biologically active agent is comprised of ribonucleic acid, deoxyribonucleic acid, protein or lipid.
7. The process according to claim 1 , wherein the α-amino acid is arginine, histidine, or lysine.
8. The process according to claim 1 , wherein the α-amino acid is serine, threonine, asparagine, or glutamine.
9. The process according to claim 1 , wherein the α-amino acid is aspartic acid or glutamic acid.
10. The process according to claim 1 , wherein the α-amino acid is alanine, valine, isoleucine, leucine, methionine, phenylalanine, tyrosine, or tryptophan.
11. The process according to claim 1 , wherein the α-amino acid is cysteine, selenocysteine, glycine, or proline.
12. The process according to claim 1 , wherein the α-amino acid is selected from the group consisting of arginine, histidine, lysine, serine, threonine, asparagine, glutamine, aspartic acid, glutamic acid, alanine, valine, isoleucine, leucine, methionine, phenylalanine, tyrosine, tryptophan, cysteine, selenocysteine, glycine, proline, and mixtures thereof.
13. The process according to claim 4 , wherein the α-amino acid is arginine, histidine, or lysine.
14. The process according to claim 4 , wherein the α-amino acid is serine, threonine, asparagine, or glutamine.
15. The process according to claim 4 , wherein the α-amino acid is aspartic acid or glutamic acid.
16. The process according to claim 4 , wherein the α-amino acid is alanine, valine, isoleucine, leucine, methionine, phenylalanine, tyrosine, or tryptophan.
17. The process according to claim 4 , wherein the α-amino acid is cysteine, selenocysteine, glycine, or proline.
18. The process according to claim 4 , wherein the α-amino acid is selected from the group consisting of arginine, histidine, lysine, serine, threonine, asparagine, glutamine, aspartic acid, glutamic acid, alanine, valine, isoleucine, leucine, methionine, phenylalanine, tyrosine, tryptophan, cysteine, selenocysteine, glycine, proline, and mixtures thereof.